2012年
- D. Iohara, K. Yoshida, K. Yamaguchi, M. Anraku, K. Motoyama, H. Arima, K. Uekama and F. Hirayama,
Cyclodextrin-induced Change in Crystal Habit of Acetylsalicylic Acid in Aqueous Solution,
Cryst. Growth Des., 12(4), 1985-1991 (2012).
- M. Anraku, H. Tomida, A. Michihara, D. Tsuchiya, D. Iohara, Y. Maezaki, K. Uekama, T. Maruyama, M. Otagiri and F. Hirayama,
Antioxidant and Renoprotective Activity of Chitosan in Nephrectomized Rats,
Carbohydr. Polym., 89, 302-304 (2012).
- H. Arima, M. Arizono, T. Higashi, A. Yoshimatsu, H. Ikeda, K. Motoyama, K. Hattori, T. Takeuchi, F. Hirayama and K. Uekama,
Potential Use of Folate-polyethylene glycol (PEG)-Appended Dendrimer (G3) Conjugate with a-Cyclodextrin as DNA Carriers to Tumor Cells,
Cancer Gene Ther., 19(5), 358-366 (2012).
- T. Anno, T. Higashi, K. Motoyama, F. Hirayama, K. Uekama and H. Arima,
Possible Enhancing Mechanisms for Gene Transfer Activity of Glucuronylglucosyl-β-cyclodextrin/dendrimer Conjugate (G2),
Int. J. Pharm., 426(1-2), 239-247 (2012).
- D. Iohara, M. Hiratsuka, F. Hirayama, K. Takeshita, K. Motoyama, H. Arima and K. Uekama,
Evaluation of photodynamic activity of C60/2-hydroxypropyl-β-cyclodextrin nanoparticles,
J. Pharm. Sci.,101(9), 3390-3397 (2012).
- T. Anno, T. Higashi, K. Motoyama, F. Hirayama, K. Uekama and H. Arima ,
Potential use of glucuronylglucosyl-β-cyclodextrin/dendrimer conjugate (G2) as a DNA carrier in vitro and in vivo,
J. Drug Target., 20(3), 272-280 (2012).
- K. Uehata, T. Anno, K. Hayashida, T. Higashi, K. Motoyama, F. Hirayama, K. Uekama and H. Arima,
Peak-less Hypoglycemic Effect of Insulin Glargine by Complexation with Maltosyl-β-cyclodextrin,
Int. J. Pharm., 422(1-2), 33-39 (2012).
- 本山敬一、東 大志、平山文俊、上釜兼人、有馬英俊
シクロデキストリンポリシュードロタキサンを用いたタンパク質・遺伝子徐放システム,
PHARM TECH JAPAN,28(10), 169-177 (2012).